American Portfolios Advisors’s Esperion Therapeutics ESPR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$311K	Buy	46,490 +3,540	+8%	+$24.3K	0.01%	837
2022 Q2	$273K	Hold	42,950	–	–	0.01%	912
2022 Q1	$199K	Buy	42,950 +235	+0.6%	+$1.01K	0.01%	1160
2021 Q4	$214K	Buy	42,715 +13,155	+45%	+$105K	0.01%	1129
2021 Q3	$356K	Buy	29,560 +1,125	+4%	+$16.4K	0.01%	865
2021 Q2	$601K	Buy	28,435 +3,375	+13%	+$81.3K	0.02%	632
2021 Q1	$703K	Buy	25,060 +2,875	+13%	+$84.8K	0.03%	533
2020 Q4	$577K	Buy	22,185 +1,290	+6%	+$38.6K	0.03%	515
2020 Q3	$777K	Buy	20,895 +6,140	+42%	+$243K	0.04%	363
2020 Q2	$757K	Buy	14,755 +2,910	+25%	+$122K	0.05%	337
2020 Q1	$373K	Buy	11,845 +7,425	+168%	+$392K	0.03%	443
2019 Q4	$264K	Buy	4,420 +200	+5%	+$8.99K	0.02%	641
2019 Q3	$155K	Buy	4,220 +200	+5%	+$7.92K	0.01%	802
2019 Q2	$187K	Sell	4,020 -300	-7%	-$14.1K	0.02%	735
2019 Q1	$173K	Buy	4,320 +475	+12%	+$21.3K	0.02%	688
2018 Q4	$177K	Hold	3,845	–	–	0.02%	551
2018 Q3	$171K	Buy	3,845 +700	+22%	+$32.1K	0.02%	641
2018 Q2	$123K	Sell	3,145 -2,330	-43%	-$118K	0.02%	728
2018 Q1	$396K	Hold	5,475	–	–	0.06%	318
2017 Q4	$360K	Buy	+5,475	New	+$295K	0.06%	333

Other funds holding ESPR